Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma.
about
Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells.Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agentsStudying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
P2860
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Antitumor effects of regorafen ...... s of hepatocellular carcinoma.
@en
Antitumor effects of regorafen ...... s of hepatocellular carcinoma.
@nl
type
label
Antitumor effects of regorafen ...... s of hepatocellular carcinoma.
@en
Antitumor effects of regorafen ...... s of hepatocellular carcinoma.
@nl
prefLabel
Antitumor effects of regorafen ...... s of hepatocellular carcinoma.
@en
Antitumor effects of regorafen ...... s of hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Antitumor effects of regorafen ...... s of hepatocellular carcinoma.
@en
P2093
Dieter Zopf
Frank-Thorsten Hafner
Lukas Fiebig
Maria Kissel
Michael Teufel
Qingyang Gu
Qunsheng Ji
Sandra Berndt
Simon Kling
P2860
P304
107096-107108
P356
10.18632/ONCOTARGET.22334
P407
P577
2017-11-06T00:00:00Z